Advertisement

Glycoconjugate Journal

, Volume 30, Issue 8, pp 747–757 | Cite as

Influence of ligand presentation density on the molecular recognition of mannose-functionalised glyconanoparticles by bacterial lectin BC2L-A

  • Michael Reynolds
  • Marco Marradi
  • Anne Imberty
  • Soledad Penadés
  • Serge Pérez
Article

Abstract

Polyvalent carbohydrate-protein interactions play a key role in bio- and pathological processes, including cell-cell communication and pathogen invasion. In order to study, control and manipulate these interactions gold nanoparticles have been employed as a 3D scaffold, presenting carbohydrate ligands in a multivalent fashion for use as high affinity binding partners and a model system for oligosaccharide presentation at biomacromolecular surfaces. In this study, the binding of a series of mannose-functionalised gold nanoparticles to the dimeric BC2L-A lectin from Burkholderia cenocepacia has been evaluated. BC2L-A is known to exhibit a high specificity for (oligo)mannosides. Due to the unique structure and binding nature of this lectin, it provides a useful tool to study (oligo)saccharides presented on multivalent scaffolds. Surface plasmon resonance and isothermal titration calorimetric assays were used to investigate the effect of ligand presentation density towards binding to the bacterial lectin. We show how a combination of structural complementarities between ligand presentation and lectin architecture and statistical re-binding effects are important for increasing the avidity of multivalent ligands for recognition by their protein receptors; further demonstrating the application of glyconanotechnology towards fundamental glycobiology research as well as a potential towards biomedical diagnostics and therapeutic treatments.

Keywords

Lectin Multivalency Glyconanoparticles Protein-carbohydrate interaction 

Notes

Acknowledgments

The authors wish to thank the GlycoGold research training network, a part of the sixth research framework of the European Union, contract number MRTN-CT-2004-005645, for financial support. Financial support from the CNRS and ESRF are also acknowledged as well from the Labex Arcane (ANR-11-LABX-003) and the COST actions CM1102 and BM1003. We thank also the Spanish Ministry of Science and Innovation (MICINN, grant CTQ2011-27268) and the Department of Industry of the Basque Country (Etortek 2009). Dr Emilie Lameignere is greatly appreciated for help with lectin production. The SPR experiments were ran thanks to access to a Biacore T100 at the Plateforme Nanobio-Grenoble. SAXS experiments and analysis were carried out with the help of Drs Michael Sztucki and Emanuela Di Cola (ESRF, Grenoble). Professors Monica Palcic and Johannis Kamerling are also thanked for their helpful discussion.

Supplementary material

10719_2013_9478_MOESM1_ESM.pdf (685 kb)
ESM 1 (PDF 685 kb)

References

  1. 1.
    Lis, H., Sharon, N.: Lectins: carbohydrate-specific proteins that mediate cellular recognition. Chem. Rev. 98, 637–674 (1998)PubMedCrossRefGoogle Scholar
  2. 2.
    Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., Etzler, M.E.: Essentials of Glycobiology, 2nd edn. Cold Spring Harbour, New York (2009)Google Scholar
  3. 3.
    Kramer, R.H., Karpen, J.W.: Spanning binding sites on allosteric proteins with polymer-linked ligand dimers. Nature 395, 710–713 (1998)PubMedCrossRefGoogle Scholar
  4. 4.
    Gargano, J.M., Ngo, T., Kim, J.Y., Acheson, D.W., Lees, W.J.: Multivalent inhibition of AB(5) toxins. J. Am. Chem. Soc. 123, 12909–12910 (2001)PubMedCrossRefGoogle Scholar
  5. 5.
    Mammen, M., Choi, S.K., Whitesides, G.M.: Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Ed. 37, 2755–2794 (1998)CrossRefGoogle Scholar
  6. 6.
    Reynolds, M., Perez, S.: Thermodynamics and chemical characterization of protein-carbohydrate interactions: the multivalency issue. C. R. Chim. 14, 74–95 (2011)CrossRefGoogle Scholar
  7. 7.
    Bernardi, A., Jimenez-Barbero, J., Casnati, A., De Castro, C., Darbre, T., Fieschi, F., Finne, J., Funken, H., Jaeger, K.E., Lahmann, M., Lindhorst, T.K., Marradi, M., Messner, P., Molinaro, A., Murphy, P.V., Nativi, C., Oscarson, S., Penadés, S., Peri, F., Pieters, R.J., Renaudet, O., Reymond, J.L., Richichi, B., Rojo, J., Sansone, F., Schaffer, C., Turnbull, W.B., Velasco-Torrijos, T., Vidal, S., Vincent, S., Wennekes, T., Zuilhof, H., Imberty, A.: Multivalent glycoconjugates as anti-pathogenic agents. Chem. Soc. Rev. (2013). doi: 10.1039/C2CS35408J
  8. 8.
    Marradi, M., Chiodo, F., Garcia, I., Penadés, S.: Glyconanoparticles as multifunctional and multimodal carbohydrate systems. Chem. Soc. Rev. (2013). doi: 10.1039/C2CS35420A
  9. 9.
    Tvaroska, I., Sihelnikova, L.: Step by step towards understanding gold glyconanoparticles as elements of the nanoworld. Chem. Pap. 61, 237–255 (2007)CrossRefGoogle Scholar
  10. 10.
    Marradi, M., Martin-Lomas, M., Penadés, S.: Glyconanoparticles polyvalent tools to study carbohydrate-based interactions. Adv. Carbohyd. Chem. Biochem. 64, 211–290 (2010)CrossRefGoogle Scholar
  11. 11.
    Boisselier, E., Astruc, D.: Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem. Soc. Rev. 38, 1759–1782 (2009)PubMedCrossRefGoogle Scholar
  12. 12.
    Otsuka, H., Akiyama, Y., Nagasaki, Y., Kataoka, K.: Quantitative and reversible lectin-induced association of gold nanoparticles modified with alpha-lactosyl-omega-mercapto-poly(ethylene glycol). J. Am. Chem. Soc. 123, 8226–8230 (2001)PubMedCrossRefGoogle Scholar
  13. 13.
    Lin, C.C., Yeh, Y.C., Yang, C.Y., Chen, C.L., Chen, G.F., Chen, C.C., Wu, Y.C.: Selective binding of mannose-encapsulated gold nanoparticles to type 1 pili in Escherichia coli. J. Am. Chem. Soc. 124, 3508–3509 (2002)PubMedCrossRefGoogle Scholar
  14. 14.
    Thygesen, M.B., Sauer, J., Jensen, K.J.: Chemoselective capture of glycans for analysis on gold nanoparticles: carbohydrate oxime tautomers provide functional recognition by proteins. Chem. Eur. J. 15, 1649–1660 (2009)PubMedCrossRefGoogle Scholar
  15. 15.
    Halkes, K.M., de Souza, A.C., Maljaars, C.E.P., Gerwig, G.J., Kamerling, J.P.: A facile method for the preparation of gold glyconanoparticles from free oligosaccharides and their applicability in carbohydrate-protein interaction studies. Eur. J. Org. Chem. 3650–3659 (2005).Google Scholar
  16. 16.
    Schofield, C.L., Mukhopadhyay, B., Hardy, S.M., McDonnell, M.B., Field, R.A., Russell, D.A.: Colorimetric detection of Ricinus communis Agglutinin 120 using optimally presented carbohydrate-stabilised gold nanoparticles. Analyst 133, 626–634 (2008)PubMedCrossRefGoogle Scholar
  17. 17.
    Martinez-Avila, O., Hijazi, K., Marradi, M., Clavel, C., Campion, C., Kelly, C., Penadés, S.: Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN. Chem. Eur. J. 15, 9874–9888 (2009)PubMedCrossRefGoogle Scholar
  18. 18.
    Martinez-Avila, O., Bedoya, L.M., Marradi, M., Clavel, C., Alcami, J., Penadés, S.: Multivalent manno-glyconanoparticles inhibit DC-SIGN-mediated HIV-1 trans-infection of human T cells. Chem Bio Chem 10, 1806–1809 (2009)PubMedCrossRefGoogle Scholar
  19. 19.
    Marradi, M., Di Gianvincenzo, P., Enriquez-Navas, P.M., Martinez-Avila, O.M., Chiodo, F., Yuste, E., Angulo, J., Penadés, S.: Gold nanoparticles coated with oligomannosides of HIV-1 glycoprotein gp120 mimic the carbohydrate epitope of antibody 2G12. J. Mol. Biol. 410, 798–810 (2011)PubMedCrossRefGoogle Scholar
  20. 20.
    Wang, X., Matei, E., Gronenborn, A.M., Ramstrom, O., Yan, M.: Direct measurement of glyconanoparticles and lectin interactions by isothermal titration calorimetry. Anal. Chem. 84, 4248–4252 (2012)PubMedCrossRefGoogle Scholar
  21. 21.
    Reynolds, M., Marradi, M., Imberty, A., Penades, S., Perez, S.: Multivalent gold glycoclusters: high affinity molecular recognition by bacterial lectin PA-IL. Chem. Eur. J. 18, 4264–4273 (2012)PubMedCrossRefGoogle Scholar
  22. 22.
    Govan, J.R., Deretic, V.: Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60, 539–574 (1996)PubMedGoogle Scholar
  23. 23.
    Lyczak, J.B., Cannon, C.L., Pier, G.B.: Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15, 194–222 (2002)PubMedCrossRefGoogle Scholar
  24. 24.
    Lameignere, E., Malinovska, L., Slavikova, M., Duchaud, E., Mitchell, E.P., Varrot, A., Sedo, O., Imberty, A., Wimmerova, M.: Structural basis for mannose recognition by a lectin from opportunistic bacteria Burkholderia cenocepacia. Biochem. J. 411, 307–318 (2008)PubMedCrossRefGoogle Scholar
  25. 25.
    Sulak, O., Cioci, G., Delia, M., Lahmann, M., Varrot, A., Imberty, A., Wimmerova, M.: A TNF-like trimeric lectin domain from Burkholderia cenocepacia with specificity for fucosylated human histo-blood group antigens. Structure 18, 59–72 (2010)PubMedCrossRefGoogle Scholar
  26. 26.
    Sulak, O., Cioci, G., Lameignere, E., Balloy, V., Round, A., Gutsche, I., Malinovska, L., Chignard, M., Kosma, P., Aubert, D.F., Marolda, C.L., Valvano, M.A., Wimmerova, M., Imberty, A.: Burkholderia cenocepacia BC2L-C is a super lectin with dual specificity and proinflammatory activity. PLoS Pathog 7, e1002238 (2011)PubMedCrossRefGoogle Scholar
  27. 27.
    Lameignere, E., Shiao, T.C., Roy, R., Wimmerova, M., Dubreuil, F., Varrot, A., Imberty, A.: Structural basis of the affinity for oligomannosides and analogs displayed by BC2L-A, a Burkholderia cenocepacia soluble lectin. Glycobiology 20, 87–98 (2010)PubMedCrossRefGoogle Scholar
  28. 28.
    Mandal, D.K., Kishore, N., Brewer, C.F.: Thermodynamics of lectin-carbohydrate interactions. Titration microcalorimetry measurements of the binding of N-linked carbohydrates and ovalbumin to concanavalin A. Biochemistry 33, 1149–1156 (1994)PubMedCrossRefGoogle Scholar
  29. 29.
    Rieger, J., Stoffelbach, F., Cui, D., Imberty, A., Lameignere, E., Putaux, J.L., Jerome, R., Jerome, C., Auzely-Velty, R.: Mannosylated poly(ethylene oxide)-b-poly(epsilon-caprolactone) diblock copolymers: synthesis, characterization, and interaction with a bacterial lectin. Biomacromolecules 8, 2717–2725 (2007)PubMedCrossRefGoogle Scholar
  30. 30.
    Rieger, J., Freichels, H., Imberty, A., Putaux, J.L., Delair, T., Jerome, C., Auzely-Velty, R.: Polyester nanoparticles presenting mannose residues: toward the development of new vaccine delivery systems combining biodegradability and targeting properties. Biomacromolecules 10, 651–657 (2009)PubMedCrossRefGoogle Scholar
  31. 31.
    Sztucki, M., Narayanan, T.: Development of an ultra-small-angle X-ray scattering instrument for probing the microstructure and the dynamics of soft matter. J. Appl. Crystallogr. 40, S459–S462 (2007)CrossRefGoogle Scholar
  32. 32.
    Hostetler, M.J., Wingate, J.E., Zhong, C.-J., Harris, J.E., Vachet, R.W., Clark, M.R., Londono, J.D., Green, S.J., Stokes, J.J., Wignall, G.D., Glish, G.L., Porter, M.D., Evans, N.D., Murray, R.W.: Alkanethiolate gold cluster molecules with core diameters from 1.5 to 5.2 nm: core and monolayer properties as a function of core size. Langmuir 14, 17–30 (1998)CrossRefGoogle Scholar
  33. 33.
    Jadzinsky, P.D., Calero, G., Ackerson, C.J., Bushnell, D.A., Kornberg, R.D.: Structure of a thiol monolayer-protected gold nanoparticle at 1.1 A resolution. Science 318, 430–433 (2007)PubMedCrossRefGoogle Scholar
  34. 34.
    Huang, W., Bulusu, S., Pal, R., Zeng, X.C., Wang, L.S.: Structural transition of gold nanoclusters: from the golden cage to the golden pyramid. ACS Nano 3, 1225–1230 (2009).Google Scholar
  35. 35.
    Chien, Y.Y., Jan, M.D., Adak, A.K., Tzeng, H.C., Lin, Y.P., Chen, Y.J., Wang, K.T., Chen, C.T., Chen, C.C., Lin, C.C.: Globotriose-functionalized gold nanoparticles as multivalent probes for Shiga-like toxin. Chem Bio Chem 9, 1100–1109 (2008)PubMedCrossRefGoogle Scholar
  36. 36.
    Kulkarni, A.A., Fuller, C., Korman, H., Weiss, A.A., Iyer, S.S.: Glycan encapsulated gold nanoparticles selectively inhibit shiga toxins 1 and 2. Bioconjugate Chem. 21, 1486–1493 (2010)CrossRefGoogle Scholar
  37. 37.
    Hill, H.D., Millstone, J.E., Banholzer, M.J., Mirkin, C.A.: The role radius of curvature plays in thiolated oligonucleotide loading on gold nanoparticles. ACS Nano 3, 418–424 (2009)PubMedCrossRefGoogle Scholar
  38. 38.
    Cederquist, K.B., Keating, C.D.: Curvature effects in DNA:Au nanoparticle conjugates. ACS Nano 3, 256–260 (2009)PubMedCrossRefGoogle Scholar
  39. 39.
    Schreiber, F.: Structure and growth of self-assembling monolayers. Prog. Surf. Sci. 65, 151–256 (2000)CrossRefGoogle Scholar
  40. 40.
    Rojo, J., Diaz, V., de la Fuente, J.M., Segura, I., Barrientos, A.G., Riese, H.H., Bernad, A., Penadés, S.: Gold glyconanoparticles as new tools in antiadhesive therapy. Chem Bio Chem 5, 291–297 (2004)PubMedCrossRefGoogle Scholar
  41. 41.
    Sisu, C., Baron, A.J., Branderhorst, H.M., Connell, S.D., Weijers, C.A., de Vries, R., Hayes, E.D., Pukin, A.V., Pieters, R.J., Zuihof, H., Visser, G.M., Turnbull, W.B.: The influence of ligand valency on aggregation mechanisms for inhibiting bacterial lectins.Chem Bio Chem. 10, 329–337 (2009)Google Scholar
  42. 42.
    De, M., You, C.C., Srivasta, S., Rotello, V.M.: Biomimetic interactions of proteins with functionalized nanoparticles. J Am Chem Soc. 129, 10747–10753 (2009)Google Scholar
  43. 43.
    Nzula, S., Vandamme, P., Govan, J.R.: Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex. J. Antimicrob. Chemother. 50, 265–269 (2002)PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Michael Reynolds
    • 1
    • 2
  • Marco Marradi
    • 3
  • Anne Imberty
    • 1
  • Soledad Penadés
    • 3
  • Serge Pérez
    • 1
  1. 1.Centre de Recherche sur les Macromolécules Végétales (CERMAV – CNRS)affiliated with Université Joseph Fourier Grenoble and ICMGGrenobleFrance
  2. 2.European Synchrotron Radiation FacilityGrenoble cedex 9France
  3. 3.Biofunctional Nanomaterials UnitBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN)San SebastianSpain

Personalised recommendations